期刊文献+

多发性硬化疾病50例MRI诊断分析 被引量:4

To investigate the clinical and imaging characteristics of multiple sclerosis MS
下载PDF
导出
摘要 目的探讨多发性硬化(MS)疾病的临床及核磁共振(MRI)信号特点。方法对50例MS患者的部位、范围、病变处形态、MRI信号及强化程度进行回顾性分析。结果MS的特征性表现为同时累及多个不同的部位的斑片状T1WI低或等信号,T2WI高信号影,增强扫描后活动期病变明显强化,静止期病变无强化或强化减弱。结论MRI定位准确,不仅有助于MS的诊断及鉴别诊断,而且是目前MS最敏感的影像学检查手段。它为临床诊断及治疗、疗效评价提供了重要信息。 ObjeCtive To investigate the clinical and imaging characteristics of multiple sclerosis(MS). Methods MRI findings in 50 cases with MS, including the location, extent and shape of the lesions, as well as the signal and enhancement of the lesions, were analyzed retrospectively. Results The characteristic value performance of MS is :Simultaneously implicates many different locations, the signal were manifested as patches in shape with high signal change on T2WI and low -or iso -signal on T1 WI ;after enhancement scanning active stage lesions present obvious enhancement effect, repose period lesions present the non - enhancement effect or the enhancement effect are weaken. Conclusion MRI locates accurately, not only is helpful to the MS diagnosis and the distinction diagnosis moreover is the present MS most sensitive mescal imaging inspection method. It for the clinical diagnosis and the treatment, the curative effect appraisal has provided the important information.
作者 李大创
机构地区 南宁市
出处 《临床和实验医学杂志》 2008年第6期132-133,共2页 Journal of Clinical and Experimental Medicine
关键词 多发性硬化 磁共振成像 诊断 Multiple sclerosis MRI Diagnosis.
  • 相关文献

参考文献3

二级参考文献14

  • 1史玉泉.实用神经病学[M].上海:上海科学技术出版社,1994.1076. 被引量:189
  • 2Chen SC, Chung HW, Liou M. Measurement of volumetric lesion load in multiple sclerosis: moving from normal-to dirty-appearing white matter. Am J Neuroradiol J, 2003,24(10):1929-1930 被引量:1
  • 3Ge YL, Grossman RI, Babb JS, et al. Dirty-appearing white matter in multiple sclerosis: volumetie MR imaging and magnetization transfer ratio histogram analysis. Am J Neuroradiol, 2003,24(10):1935-1940 被引量:1
  • 4Adalsteinsson E, Langer-Gould A. Homer RJ, et al. Gray matter N-acetyl aspartate deficits in secondary progressive but not relapsing-remitting multiple sclerosis Am J Neuroradiol, 2003, 24(10):1941-1945 被引量:1
  • 5Poser CM,Party DW,Scheinber L,et al.New diagnostic criteria for multiple sclerosis:guide lines for research protocols[J].Ann Neurol,1983,33(2):227-231. 被引量:1
  • 6Poser CM,Brinar VV.Epilepsy and multiple scleros[J].Epilepsy and Behavior,2003,4(1):6-12. 被引量:1
  • 7Striano P,Orefice G,Brescia Morra V,et al.Epileptic seizures in multiple sclerosis:clinical and EEG correlations[J].Neurosci,2003,24(5):322-328. 被引量:1
  • 8史玉泉.实用神经病学[M].2版.上海:上海科技出版社,1994:789. 被引量:69
  • 9Sokic D,Stojsavlevic N,Drulovic J,et al.Seizures in multiple sclerosis[J].Eilesia,2001,42(1):72-79. 被引量:1
  • 10Mc Donald WI,Compston A,Edan G,et al.Recommended diagnostic criteria for mutiple sclerosis:guidelines from the international panel on the diagnosis of mutiple sclerosis[J].Ann Neuro,2001,50:121-127. 被引量:1

共引文献3

同被引文献31

  • 1于春水,李坤成,段云云,秦文.182例多发性硬化临床与MRI分析[J].中国医学影像技术,2005,21(5):684-686. 被引量:24
  • 2杨淞然,蒋少艾,潘小平,李泽.脑型多发性硬化的磁共振影像学分析[J].岭南急诊医学杂志,2007,12(3):185-186. 被引量:5
  • 3Grigoriadis N, Grigoriadis S’ Polyzoidou E, et al. Neuroin*flammation in multiple sclerosis ? evidence for autoimmunedysregulation, not simple autoimmune reaction [J]. ClinNeurol Neurosurg,2006,108 : 241-2544. 被引量:1
  • 4Soon D, Tozer DJ,Altmann DR,et al. Quantification of sub-tle blood-brain barrier disruption in non-enhancing lesions inmultiple sclerosis: a study of disease and lesion subtypes [J].Mult Scler,2007, 13: 884-894. 被引量:1
  • 5Yong VW. Differential mechanisms of action of interferon-be-ta and glatiramer acetate in MS [J]. Neurology,2002,59:802-808. 被引量:1
  • 6Filippi M,Rovaris M,Rocca M, et al. Glatiramer acetate re-duces the proportion of new MS lesions evolving into u blackholes” [J] . Neurology, 2001, 57: 731-733. 被引量:1
  • 7Sawcer S. The complex genetics of multiple sclerosis: pitfallsand prospects [J]. Brain, 2008,131 : 3118-3131. 被引量:1
  • 8Fisniku LK, Brex PA, Altmann DR, et al. Disability and T2MRI lesions: a 20-year follow-up of patients with relapse on-set of multiple sclerosis [J]. Brain,2008,131 : 808-817. 被引量:1
  • 9Daumer M,Neuhaus A,Morrissey S, et al. MRI as an out-come in multiple sclerosis clinical trials [J]. Neurology,2009, 72: 705-711. 被引量:1
  • 10Li DK, Held U, Petkau J,et al. MRI Tz lesion burden inmultiple sclerosis: a plateauing relationship with clinical disa-bility [J]. Neurology, 2006, 66: 1384-1389. 被引量:1

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部